Additionally, our study detailed roles of STYK1 in the regulation of autophagy which showed interplay with EGFR-TKI and also provided a proof of concept for a therapeutic strategy against NSCLC development and EGFR-TKI resistance. This evidence concerns the gene EGFR and non-small cell lung carcinoma.